Search for Clinical Trial Results
Adenocarcinoma, Bronchiolo-Alveolar - 105 Studies Found
Status | Study |
Terminated |
Study Name: A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer Condition: Lung Cancer, Non-Small Cell Date: 2003-11-13 Interventions: Drug: GW572016 (lapatinib) tyrosine kinase inhibitor |
Active, not recruiting |
Study Name: Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer Condition:
|
Completed |
Study Name: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Condition:
|
Completed |
Study Name: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer Condition:
|
Active, not recruiting |
Study Name: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Condition:
|
Completed |
Study Name: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery Condition:
|
Completed |
Study Name: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer Condition:
|
Completed |
Study Name: MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy Condition:
Date: 2011-02-10 Interventions: |
Completed |
Study Name: Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature Condition:
|
Recruiting |
Study Name: Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Condition:
Interventions: |